Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track CMPS with free AI briefings, catalyst countdowns, and dilution alerts.

CMPS

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$433.3M Cash on Hand

29.5mo Cash Runway

10% Short Interest

🧪 Upcoming Trial Catalysts

2028-06-30 · Phase 3 — Recruiting — The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Di
2028-11-01 · Phase 2, Phase 3 — Upcoming Trial — Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Pa

📊 Drug Pipeline

Drug	Indication	Phase	Status
Psilocybin	Treatment Resistant Depression	PHASE3	ACTIVE_NOT_RECRUITING
COMP360 psilocybin	PTSD - Post Traumatic Stress Disorder	PHASE2	NOT_YET_RECRUITING

💰 Cash Runway & Dilution Risk

CMPS holds $433.3M in cash and burns about $44.1M/quarter from operations, giving an estimated runway of 29.5 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for CMPS free →

📈 Recent Insider Activity (Form 4)

Date	Insider	Type	Value
2026-08-05	Nath Kabir	Sale	$4.1M
2026-05-29	JONAS JEFFREY M	Purchase	$0
2026-05-29	SANTINI GINO	Purchase	$0
2026-05-29	Riley Wayne Joseph	Purchase	$0
2026-05-29	Norton David Y	Purchase	$0

Get the full CMPS picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for CMPS and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z